Hong Kong-listed cardiovascular medical devices developer Venus Medtech, Asia-focused private equity firm DCP Capital, and Chinese venture capital firm Qiming Venture Partners have inked an agreement to launch a healthcare investment platform.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
